We recently reported that E2F1 could transactivate the p21 promoter via cis-acting elements between 7119 to +16 bp of the p21 gene. Here we show that activated V12-H-Ras can induce the p21 promoter through the same region of the p21 promoter by a p53-independent mechanism in NIH3T3 cells. In contrast, activated Ras was not able to induce the p21 promoter in E2F1 7/7 ®broblasts, suggesting that E2F1 is required for induction of the p21 promoter by activated Ras. Cotransfection of increasing concentrations of dominant negative E2F1 alone, or with dominant negative DP1 into NIH3T3 cells suppressed induction of the p21 promoter by activated Ras. These data suggest that p53-independent induction of the p21 promoter by activated Ras is mediated at least in part by E2F1. Oncogene (2000) 19, 961 ± 964.
We recently reported that E2F1 could transactivate the p21 promoter via cis-acting elements between 7119 to +16 bp of the p21 gene. Here we show that activated V12-H-Ras can induce the p21 promoter through the same region of the p21 promoter by a p53-independent mechanism in NIH3T3 cells. In contrast, activated Ras was not able to induce the p21 promoter in E2F1
®broblasts, suggesting that E2F1 is required for induction of the p21 promoter by activated Ras. Cotransfection of increasing concentrations of dominant negative E2F1 alone, or with dominant negative DP1 into NIH3T3 cells suppressed induction of the p21 promoter by activated Ras. These data suggest that p53-independent induction of the p21 promoter by activated Ras is mediated at least in part by E2F1. Oncogene (2000) 19, 961 ± 964.
Keywords: p21; Ras; E2F; transient transfection; CAT assay
The Ras family of proto-oncogenes encodes small guanine nucleotide-binding proteins that play an important role in regulation of cell proliferation.
Mutations that constitutively activate Ras are frequent in human cancers and activated Ras alone can transform immortalized cell lines, but not normal primary cells. Nevertheless, in some cases Ras can induce cell cycle arrest rather than cell proliferation. Cell cycle arrest induced by activated Ras was linked to p53-dependent Serrano et al., 1997) or p53-independent (Sewing et al., 1997; Woods et al., 1997) transactivation of the gene encoding the CDK inhibitor p21
. p53-dependent transactivation of the p21 gene was coupled to E2F-dependent transactivation of the tumor-suppressor p14 ARF (p19 ARF ) which binds to the MDM2-p53 complex and prevents p53 degradation (Bates et al., 1998; Palmero et al., 1998) . Here we show that p53-independent induction of the p21 gene by activated Ras is also E2F-dependent.
Several lines of evidence indicate that activation of cyclin D1 expression and induction of E2F-dependent transcription is downstream of the Ras/Raf/MAP kinase pathway (Aktas et al., 1997; Albanese et al., 1995; Fan and Bertino, 1997; Halaban et al., 1998; Woods et al., 1997) . Activated Ras induces the cyclin D1 promoter through AP-1-like sequences (Albanese et al., 1995) . Activation of Raf (Aziz et al., 1999) , Rac and Cdc42 (Gjoerup et al., 1998) , in NIH3T3 cells leads to induced expression of cyclin D1, stimulation of E2F-mediated transcription and accumulation of p21. Positive regulation of E2F-dependent transcription by cyclin D1 results from Rb phosphorylation by cyclin D1/CDK complexes and release of free E2F (Hiyama et al., 1997; Schulze et al., 1994) .
The E2F proteins comprise a family of six transcription factors that form heterodimers with two DP family members, and regulate transcription of several genes involved in control of cell proliferation (Dyson, 1998) . Overexpression of E2F1 may lead to apoptosis (Qin et al., 1994; Wu and Levine, 1994) or contribute to tumorigenesis (Johnson et al., 1994; Pierce et al., 1998; Xu et al., 1995) . E2F1, when overexpressed, can also activate several genes necessary for S phase progression (Lukas et al., 1996; Ohtani et al., 1995) . However, E2F1 is not required for normal G1 to S phase progression of cycling cells (Wang et al., 1998 ). An alternative role for E2F1 as an inhibitor of proliferation has also been proposed (Sellers et al., 1995) , as the RB-E2F1 complex itself can bind E2F cisacting elements in genes required for cell cycle progression and act as a transcriptional repressor (Sellers et al., 1995; Weintraub et al., 1992 Weintraub et al., , 1995 . Disruption of E2F1 in mice results in hyperplasia and tumor formation (Field et al., 1996; Yamasaki et al., 1996) , further supporting a role for E2F as a tumor suppressor and a negative regulator of cell cycle progression. E2F1 7/7 mice display visible enlargement of the thymus and lymph nodes within 1 month after birth, and increased thymocyte proliferation in aging mice.
Earlier we and others showed that E2F1 and E2F3, but not E2F4 strongly transactivate p21 transcription through cis-acting elements located between nucleotides 7119 to +16 of the p21 promoter (Gartel et al., 1998; Hiyama et al., 1998) . p21 has been shown to inhibit proliferation both in vitro and in vivo, and overexpression of p21 results in cell cycle arrest in G1 (El-Deiry et al., 1993; Harper et al., 1995) suggesting that E2F1 may direct cell cycle arrest by inducing p21. Since, activation of E2F-dependent transcription lies downstream of the Ras/Raf/MAP kinase pathway, we decided to test the hypothesis that Ras induces cell cycle arrest and activates the p21 promoter through an E2F1-dependent mechanism.
The region between 7119 and +16 bp of the p21 promoter contains a few noncanonical E2F-binding sites (Hiyama et al., 1998) , six Sp1 binding sites and some other binding sites for transcription factors, but lacks p53 binding sites (Gartel and Tyner, 1999) . After transient transfection of NIH3T3 cells with p21 promoter reporter constructs and an expression vector with activated V12-H-Ras (Qiu et al., 1995) , we found that activated Ras can transactivate a p21 promoter construct containing 7119 to +16 bp of the p21 promoter (CAT119) (Figure 1a ). These data indicate that activated Ras can induce the p21 promoter in NIH3T3 cells by a p53-independent mechanism. In addition, they indicate that activated Ras and E2F1 transactivate the p21 promoter through the same segment of the p21 promoter. Earlier Liu et al. (1996) also demonstrated that Ras can activate the p21 promoter in HeLa and PC12 cells by a p53-independent mechanism.
To further investigate the relationship between Ras activation of the p21 promoter and E2F1, we cotransfected an activated Ras expression construct and the p21 promoter reporter CAT119 into E2F1 7/7 ®broblasts (Yamasaki et al., 1996) . We did not detect induction of these p21 promoter-CAT constructs by activated Ras in E2F1 7/7 ®broblasts ( Figure 1a) . These results suggest that E2F1 is required for induction of the p21 promoter by activated Ras. Next we cotransfected increasing concentrations of an expression vector with activated Ras together with the CAT119 reporter into NIH3T3 cells or E2F1 7/7 ®broblasts (Yamasaki et al., 1996) . We found that increasing concentrations of activated Ras resulted in a 3 ± 5-fold increase in the levels of p21 promoter activation in NIH3T3 cells (Figure 1b) . In contrast, Figure 1 E2F1 is required for transactivation of the p21 promoter by activated Ras. (a) Activated Ras induces the p21 promoter in NIH3T3 cells but not in E2F1 7/7 ®broblasts. CAT assays were performed with extracts from NIH3T3 cells transfected with empty vector pcDNA3 (Invitrogen) or a V12-H-Ras expression construct and the CAT119 p21 promoter reporter construct. Transient transfections of NIH3T3 cells were performed using calcium phosphate precipitation with 4 mg of reporter plasmid and 3 mg of pCH110 (SV40-b-gal). Transient transfections of E2F1 7/7 ®broblasts were performed using Lipofectamine (Gibco-BRL) with 4 mg of reporter plasmid and 3 mg of pCH110 (SV40-b-gal). Cells were harvested 72 h after transfection, cellular extracts were prepared and CAT assays were performed as described previously (Gorman et al., 1982) . As a substrate for CAT assays we used 1-deoxy [
C]-chloramphenicol (Amersham) instead of [
14 C]-chloramphenicol. A CAT assay using deoxychloramphenicol results in only one acetylated product, which makes it easier to quantify the results (Murray et al., 1991) . Variations in transfection eciency were corrected by normalization for expression of b-galactosidase. All transfections were repeated at least three times in duplicate. Typical experiments are shown. (b) Increasing concentrations of transfected activated Ras resulted in increased levels of p21 promoter activation in NIH3T3, but not in E2F1 7/7 ®broblasts. Graphs show the fold induction of the p21 promoter relative to basal transcription by dierent concentrations of eector V12-H-Ras plasmid. CAT assays were performed with extracts from NIH3T3 cells and E2F1 7/7 ®broblasts transfected with increasing amounts of the V12-H-Ras expression construct and the CAT119 p21 promoter reporter construct. Variations in transfection eciency were corrected by normalization for expression of bgalactosidase. All transfections were repeated at least three times in duplicate. Bars represent standard deviations we did not observe induction of the p21 promoter with any amount of transfected activated Ras expression construct in E2F1 7/7 ®broblasts (Figure 1b) . These results support the idea that Ras induces the p21 promoter through an E2F1-dependent mechanism.
To directly test the hypothesis that Ras induces the p21 promoter through an E2F1-dependent mechanism in NIH3T3 cells, we used a dominant negative (DN) E2F1 construct E2F1 (1 ± 282), which encodes an E2F1 deletion mutant that lacks the transcactivation domain (Xu et al., 1994) , or a DN DP1 construct DP1 (D103 ± 126) that encodes a DP1 deletion mutant that lacks a DNA-binding domain (Wu et al., 1996) . These mutants usually compete for binding with wild type E2F1 or DP1, and speci®cally impair E2F-dependent transactivation of dierent promoters inducible by E2F1 (Xu et al., 1994; Wu et al., 1996) . Using cotransfections of E2F1 (1 ± 282) and DP1 (D103 ± 126) together with wild type E2F1 and the CAT119 p21 promoter ± reporter plasmid, we con®rmed that DN E2F1 and DN DP1 can diminish E2F1-dependent transactivation of the p21 promoter (Figure 2a ). To determine if addition of DN E2F1 or DN DP1 can diminish activation of the p21 promoter by V12-H-Ras, we contransfected NIH3T3 cells with the activated V12-H-Ras expression construct and increasing concentrations of DN E2F1. We found that 12 mg of DN E2F1 can completely suppress induction of the p21 promoter by activated Ras (Figure  2b ). Similar results were obtained when DN DP1 alone or both DN DP1 and DN E2F1 were cotransfected together with activated Ras (Figure 2c ) supporting the hypothesis that activation of p21 transcription by activated Ras in NIH3T3 cells is E2F-dependent.
Using transient transfections of NIH3T3 cells or primary mouse E2F1
7/7 ®broblasts, we found that activated Ras may induce the p21 promoter by an E2F1-dependent, p53-independent mechanism through cis-acting elements between 7119 and +16 bp of the p21 gene. We previously demonstrated that E2F1 may directly activate p21 transcription through this region (Gartel et al., 1998) , which also contains multiple Sp1 binding sites. At the present time the role of Sp1 in Ras induction of p21 transcription is unclear. In addition to its direct eect on the p21 promoter, E2F1 may also indirectly induce Sp1-dependent transcription of the p21 promoter by competing with the inhibitor histone deacetylase HDAC1 (Doetzlhofer et al., 1999) .
Induction of transcription of the gene encoding the growth inhibitor p21 by Ras and E2F1 may initially appear paradoxical, since both Ras and E2F1 are considered primarily as inducers of cell proliferation. In addition to being able to induce transcription of the p21 gene (Gartel et al., 1998) , E2F1 also induces several genes required for DNA synthesis such as dihydrofolate reductase, thymidine kinase and others (Dyson, 1998) . E2F1 also induces the cyclin E gene that can drive cells into S phase in the absence of E2F activity (Lukas et al., 1997) , and is a major downstream target of cyclin D1 (Geng et al., 1999) . Furthermore, E2F activity is rate-limiting for S phase (Dyson, 1998) . Thus, E2F1 appears to have the ability to either promote or inhibit S phase progression.
Others have shown that activation of Raf in NIH3T3 cells can promote either cell proliferation or cell cycle arrest (Sewing et al., 1997; Woods et al., 1997) . Moderate activation of Raf led to stimulation of DNA-synthesis and cell proliferation, while strong activation of Raf induced p53-independent transactivation of the p21 gene and cell-cycle arrest. Our data suggest that induction of p21 expression and cell cycle arrest by a strong Raf signal may be E2F1 dependent. NIH3T3 cells were transiently transfected with the CAT119 p21 promoter ± reporter plasmid and the V12-H-Ras expression construct and dierent combinations of DN E2F1 and DN DP1. Transient transfections of NIH3T3 cells were performed using calcium phosphate precipitation with 4 mg of reporter plasmid and 3 mg of pCH110 (SV40-b-gal). Cells were harvested 48 ± 72 h after transfection, cellular extracts were prepared and CAT assays were performed as described previously (Gorman et al., 1982) . Variations in transfection eciency were corrected by normalization for expression of b-galactosidase. All transfections were repeated at least three times in duplicate. Mechanisms determining whether a cell divides or arrests in response to dierent intensity Raf signals are not well understood. It is possible that an inhibitor of the p21 promoter may be active in promoting cell cycle progression in response to a moderate Raf signal, while a strong Raf signal may repress such an inhibitor leading to the induction of p21 transcription. A candidate inhibitor of p21 expression may be RhoA (M McMahon, personal communication) . Raf transformed cells have no focal adhesions or actin stress ®bers which is a sign of loss of Rho function (Woods et al., 1997) , and it has been shown that RhoA represses the p21 promoter (Adnane et al., 1998; Olson et al., 1998) . Thus, repression of the p21 promoter by RhoA appears to be important for transformation, while activation of the p21 promoter through an E2F-dependent mechanism may be important as a checkpoint leading to growth arrest in normal cells.
Note added in proof Kivinen et al. (1999) have also recently reported that Ras induces p21 transcription through sequences downstream of 7119 bp of the p21 promoter.
